Marker Therapeutics Inc (MRKR)

[microcapbiotech]

That's going to be tough. The AML data coming out soon is for the Active arm patients who are the sickest of the sick, so I don't expect any CR's with them (I hope I'm wrong).
Maybe next year we will get some CR's in the Adjuvant arm patients, but from what I understand, the adjuvant patients will have to be monitored for a much longer time period.
I hope it doesn't happen, but I have kind of resigned myself to a reverse split in the next month.
If it happens, the new higher price will start to drop down (as normal) and then I will just buy more shares.